agr functionality affects clinical outcomes in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia
Authors:
- the Korea INfectious Diseases (KIND) study groupTGthe Korea INfectious Diseases (KIND) study group
- Y.-S. KimYKY.-S. Kim
- 21 June 2017
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 36 (11) , 2187-2191
Abstract
Methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) often persists despite appropriate antibiotic therapy. It is unclear what microbiological factors contribute to poor clinical outcomes in persistent MRSAB (pMRSAB). We aimed to identify clinical and microbiological risk factors for in-hospital mortality in pMRSAB. We analysed MRSAB cases prospectively collected between 2009 and 2016 at 11 hospitals in Korea, defining cases of pMRSAB as MRSAB lasting ≥5 days despite administration of effective antibiotics. The first blood isolates from the pMRSAB cases were tested for staphylococcal cassette chromosome mec type, staphylococcal protein A type, accessary gene regulator (agr) type, genes for Panton-Valentine leukocidin and phenol-soluble modulin-mec, vancomycin minimum inhibitory concentration, vancomycin heteroresistance, and agr functionality. We also collected clinical information for each case. Of 960 MRSAB cases, 152 pMRSAB were finally eligible. Univariable analysis revealed that in-hospital mortality was significantly associated with Charlson’s comorbidity-weighted index (CCWI) score, Pitt bacteremia score, sequential organ failure assessment score, presentation with septic shock, pneumonia, agr dysfunction, and vancomycin heteroresistance. Bone and joint infections were negatively associated with in-hospital mortality. Multivariable analysis revealed the following independent risk factors for in-hospital mortality: CCWI score [adjusted odds ratio (aOR), per one point, 1.25; 95% confidence interval (CI), 1.08–1.44; P = 0.003), Pitt bacteremia score (aOR, per one point, 1.33; 95% CI, 1.09–1.62; P = 0.005), non-eradicated foci of infection (aOR, 3.12; 95% CI, 1.18–8.27; P = 0.022), and agr dysfunction (aOR, 2.48; 95% CI, 1.12–5.47; P = 0.025). agr dysfunction is an independent risk factor for in-hospital mortality in pMRSAB.Keywords
Funding Information
- Seoul National University Bundang Hospital Research Fund (14-2016-002)
This publication has 18 references indexed in Scilit:
- Impact of area under the concentration–time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemiaInternational Journal of Antimicrobial Agents, 2015
- agr Dysfunction Affects Staphylococcal Cassette Chromosome mec Type-Dependent Clinical Outcomes in Methicillin-Resistant Staphylococcus aureus BacteremiaAntimicrobial Agents and Chemotherapy, 2015
- What role does the quorum-sensing accessory gene regulator system play during Staphylococcus aureus bacteremia?Trends in Microbiology, 2014
- Characteristics of invasive Staphylococcus aureus infections in three regions of Korea, 2009-2011: a multi-center cohort studyBMC Infectious Diseases, 2013
- Complete Genome Sequence of a Pantón-Valentine Leukocidin-Negative Community-Associated Methicillin-Resistant Staphylococcus aureus Strain of Sequence type 72 from KoreaPLOS ONE, 2013
- Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemiaJournal of Antimicrobial Chemotherapy, 2013
- Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in TaiwanJournal of Antimicrobial Chemotherapy, 2010
- Persistent Staphylococcus aureus BacteremiaAn Analysis of Risk Factors and OutcomesArchives of internal medicine (1960), 2007
- International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum β-Lactamase Production in Nosocomial InfectionsAnnals of Internal Medicine, 2004
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987